Cargando…
Cellular based immunotherapy for primary liver cancer
Primary liver cancer (PLC) is a common malignancy with high morbidity and mortality. Poor prognosis and easy recurrence on PLC patients calls for optimizations of the current conventional treatments and the exploration of novel therapeutic strategies. For most malignancies, including PLC, immune cel...
Autores principales: | Zheng, Yuanyuan, Li, Yan, Feng, Jiao, Li, Jingjing, Ji, Jie, Wu, Liwei, Yu, Qiang, Dai, Weiqi, Wu, Jianye, Zhou, Yingqun, Guo, Chuanyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351445/ https://www.ncbi.nlm.nih.gov/pubmed/34372912 http://dx.doi.org/10.1186/s13046-021-02030-5 |
Ejemplares similares
-
Current status of ctDNA in precision oncology for hepatocellular carcinoma
por: Li, Yan, et al.
Publicado: (2021) -
Correction to: Current status of ctDNA in precision oncology for hepatocellular carcinoma
por: Li, Yan, et al.
Publicado: (2021) -
Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma
por: Feng, Jiao, et al.
Publicado: (2020) -
Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma
por: Yu, Qiang, et al.
Publicado: (2020) -
Promotion of colorectal cancer cell death by ezetimibe via mTOR signaling-dependent mitochondrial dysfunction
por: Zheng, Yuanyuan, et al.
Publicado: (2023)